Workers suffer as profitable pharma firms axe French jobs


On Tuesday February 2nd France's pharmaceuticals giant Sanofi announced that it would be shedding up to 600 jobs over three years. Just before Christmas another drug maker, Servier, revealed that more than 600 posts will go, while Swiss company Novartis is also discreetly losing up to 200 positions in France. The news of the job losses comes despite the fact that some of the firms are not only profitable but have also been picking up taxpayers' cash aimed at protecting employment. Mathilde Goanec reports.

Reading articles is for subscribers only. Subscribe now.

The last few months have proved grim ones for staff at some of France's leading pharmaceutical firms. On Tuesday, February 2nd, the giant drugs company Sanofi announced that it would be losing up to 600 jobs over the next three years in France. But less well-documented was the announcement before Christmas that the drugmakers Servier would also be shedding more than 600 jobs.